Michelle Ngo

Practice Details

• Firm Information
  Position

  Associate

  Firm Name

  Duane Morris LLP
• Representative Cases & Transactions
  Cases

  Representative Matters: Represented Catalent, Inc. (NYSE: CTLT), a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies
  consumer health products, in its $80 million acquisition of the manufacturing
  packaging operations of Acorda Therapeutics, Inc. (Nasdaq: ACOR).
  Represented Jornaya, a leading provider of consumer behavioral data
  intelligence, in its sale to Verisk (Nasdaq: VRSK), a leading data analytics provider, serving customers in insurance, energy
  specialized markets,
  financial services.
  Advised Smartlink, a wireless communications company,
  its owners in connection with an investment from McCarthy Capital Partners, a middle market private equity fund,
  an equity raise
  concurrent recapitalization of prior investment.
  Represented BFS Capital, Inc., a leading small business lender, in its Series B Preferred offering led by Edison Partners
  Honeywell International, Inc. Master Retirement Trust.
  Advised the Special Committee of the Board of Directors of Customers Bancorp, Inc. (NYSE: CUBI) in the $140 million merger of its subsidiary, BankMobile Technologies, Inc., one of the largest digital banking platforms in the U.S., with Megalith Financial Acquisition Corp. (NYSE: MFAC), a special purpose acquisition company, or SPAC,
  in related PIPE, strategic licensing
  other transactions to finance
  support the merger.
  Represented a French listed company in its acquisition of a US-based provider of museum exhibit project management, production
  technology services.
  Represented an investment bank, as placement agent, in a PIPE transaction consisting of shares of common stock
  warrants for a NASDAQ-listed specialty biopharmaceutical company.
  Represented Pennsylvania Machine Works LLC, a leading manufacturer in the forged pressure fitting industry, in connection with the multimillion-dollar sale of all of its outst
  ing equity to Wynnchurch Capital Partners.
  Represented Texas Hospice Holdings, LLC, a multi-state hospice facility operator, in connection with the sale of all of its outst
  ing equity to Amedisys Inc., a publicly-held hospice company.